Yes, patients with gout should take both allopurinol and indomethacin concurrently, but with specific timing and duration guidelines.
When initiating urate-lowering therapy (ULT) with allopurinol for gout, you must provide concomitant anti-inflammatory prophylaxis with agents like indomethacin (or other NSAIDs, colchicine, or corticosteroids) for 3-6 months to prevent gout flares during the critical period when urate levels are being lowered. 1
The Evidence-Based Approach
Starting Allopurinol with Anti-inflammatory Prophylaxis
The 2020 American College of Rheumatology guidelines provide a strong recommendation (moderate certainty evidence) for initiating concomitant anti-inflammatory prophylaxis therapy when starting any ULT 1. This recommendation is based on 8 randomized controlled trials and 2 observational studies demonstrating that prophylaxis significantly reduces flare risk during ULT initiation.
The Rationale
When you start lowering serum urate with allopurinol, the mobilization of urate crystals from tissue deposits paradoxically triggers acute gout flares. Anti-inflammatory prophylaxis prevents these flares during this vulnerable period. The guidelines emphasize that prophylaxis should continue for 3-6 months rather than less than 3 months, with ongoing evaluation and continuation as needed if flares persist 1.
Practical Implementation Algorithm
Step 1: Initiate Low-Dose Allopurinol
- Start allopurinol at ≤100 mg/day (even lower if CKD stage ≥3) 1, 2
- The FDA label confirms starting with 100 mg daily and increasing weekly by 100 mg increments 2
- Target serum uric acid <6 mg/dL
Step 2: Start Concurrent Anti-inflammatory Prophylaxis
Choose based on patient factors:
- Indomethacin 50 mg three times daily (as used in clinical trials) 3
- Colchicine 0.6 mg twice daily
- NSAIDs (other options)
- Prednisone/prednisolone (if NSAIDs/colchicine contraindicated)
Step 3: Duration of Prophylaxis
- Continue for minimum 3-6 months 1
- Monitor for breakthrough flares
- Continue longer if flares persist after 6 months
Step 4: Titrate Allopurinol
- Increase dose weekly by 100 mg increments 2
- Maximum FDA-approved dose: 800 mg/day 1, 2
- Adjust based on serum urate levels and renal function
Critical Timing Consideration
You can start allopurinol even during an acute gout flare (conditional recommendation) 1. A 2012 randomized trial demonstrated that initiating allopurinol 300 mg daily during an acute attack (while treating with indomethacin 50 mg three times daily) caused no significant difference in daily pain or recurrent flares compared to delayed initiation 3. This approach offers time efficiency and capitalizes on patient motivation during symptomatic periods.
Common Pitfalls to Avoid
Starting allopurinol without prophylaxis: This is the most common error and leads to precipitating acute flares, causing patients to discontinue ULT 4
Starting allopurinol at too high a dose: The FDA label explicitly warns against this, recommending 100 mg daily initially 2. Higher starting doses increase risk of allopurinol hypersensitivity syndrome 1, 2
Stopping prophylaxis too early: Durations <3 months are associated with flares upon cessation 1
Discontinuing allopurinol if a flare occurs: Continue both medications through any breakthrough flares 1
Special Populations
Chronic Kidney Disease (CKD Stage ≥3)
- Start allopurinol at ≤50 mg/day 1
- With creatinine clearance 10-20 mL/min: maximum 200 mg/day 2
- With creatinine clearance <10 mL/min: maximum 100 mg/day 2
- Caution: Hypersensitivity reactions may be increased in patients with decreased renal function receiving thiazides and allopurinol concurrently 2
Gastrointestinal Considerations
- Allopurinol is better tolerated when taken following meals 2
- If indomethacin causes GI issues, switch to colchicine or corticosteroids for prophylaxis
Monitoring Requirements
- Serum uric acid: Check regularly during dose titration (typically every 2-4 weeks)
- Renal function: Baseline and periodic monitoring, especially with CKD
- Liver function: If anorexia, weight loss, or pruritus develop 2
- Skin reactions: Discontinue immediately if rash appears 2
The Bottom Line
The combination of allopurinol and indomethacin is not just acceptable—it is the evidence-based standard of care when initiating ULT for gout. The key is understanding that these medications serve different purposes: allopurinol lowers urate long-term (the definitive treatment), while indomethacin prevents the flares that would otherwise occur during this critical transition period. This dual approach, maintained for 3-6 months, maximizes treatment success and patient adherence 1.